The Cost of Doing Business

Hello trader, Merry Christmas Y’all. Enjoy your day off from trading… But don’t get too comfortable. We’ll be back in the saddle shortly— ready, willing, and able—TO DISRESPECT THESE MARKETS. And while I might already be a multimillionaire under 30… I’ll tell you this… It’s not about the money for me anymore. It’s all about cracking this puzzle they call the stock market. Each month I pay thousands of dollars for real-time information, research, and other alerts. I probably spend more money on trading-related expenses than most people my age spend on their apartment rent. The more money you spend… the more access you can get… and in this game… information is the hottest commodity. While some people might think I’m a success or a big shot trader. In the grand scheme of things… I don’t even show up on the radar. Let’s not kid ourselves, the market doesn’t care about Kyle Dennis, the global market cap of the NYSE was reported to be somewhere north of $28 TRILLION dollars. So yeah, the near $8 million I’ve gained from trading over the last six years is SMALL FRIES. I get that. But do you know who isn’t small? The financial institutions… I’m talking about pension funds, hedge funds, mutual funds, and sovereign wealth funds. When they sneeze the market takes notice. This cartel of funds practically control the market. [And that’s why I stalk their every move in the options market.]( Why? Because they love trading options because of leverage and the ability for them to control risk. You see, they aren’t throwing out one lot trades to test the water. They’re throwing down massive bets, sometimes several million dollars on a trade (which on paper, looks like a long shot). [And I’m right there behind them, trying to get paid on the same idea.]( I use a real-time scanner that allows me to pick up on the biggest trades in the options market. And while it does throw a lot of noise, I’ve been tweaking it, with my own proprietary filters and the results have been nothing short of phenomenal. [It’s like having tomorrow’s paper—TODAY.]( All jokes aside… it’s pretty darn close. Here’s just one example of its magic: Not only was I in the trade beforehand… So were several Dollar Ace subscribers. And while some of them are thanking me for the trade, it’s them that had the courage to trust the system and to follow through on it. And as for the trade, they should be thanking the smart money who tipped me off on the trade. [Dollar Ace takes the guesswork out of trading.]( And you know what else? [This is when Dollar Ace is the most clutch.]( It’s no secret that trading volumes are drying up because of the holiday season. And it usually stays like that for a couple of weeks after. Finding good trades just becomes so much harder under those conditions. [However, with Dollar Ace, the trades find us.]( [It doesn’t get easier than that, does it?]( [See you inside!]( Kyle Dennis [Special]( RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative’s own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.